GIP and hydrops fetalis: A summary of the characteristics and results of HF, kidney, and metabolic outcome trials with SGLT2is, GLP-1 RAs, dual GIP/GLP-1 RAs, and nsMRAs published in 2024 is listed in Tables1, 2, 3, 4, 5 and 6.